The impact of insulin resistance on proinsulin secretion in pregnancy: Hyperproinsulinemia is not a feature of gestational diabetes

Diabetes Care

Volumn 28, Issue 11, 2005, Pages 2710-2715

  Retnakaran, Ravi ^a,b   Hanley, Anthony J G ^a,b   Sermer, Mathew ^b   Zinman, Bernard ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; PROINSULIN; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PATIENT CODING; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVALENCE; SCORING SYSTEM; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; VALIDATION PROCESS; AREA UNDER THE CURVE; BLOOD; CROSS-SECTIONAL STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROINSULIN;

EID: 33644788897     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.28.11.2710     Document Type: Article

References (29)

1. Porte D Jr, Kahn SE: Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction. Diabetes 38:1333-1336, 1989
2. Saad MF, Kahn SE, Nelson RG, Pettit DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr: Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990
3. Mykkanen L, Zaccaro D, Hales CN, Festa A, Haffner SM: The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 42:1060-1066, 1999
4. Mykkannen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M: Serum proinsulin levels are disproportionately increased in early prediabetic subjects. Diabetologia 35:1176-1182, 1995
5. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173-179, 1995
6. Hanley AJ, D'Agostino R Jr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM: Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the Insulin Resistance Atherosclerosis Study. Diabetes 51:1263-1270, 2002
7. Haffner SM, Stern MP, Miettinen H, Gingerich R, Bowsher RR: Higher proinsulin and specific insulin are both associated with a parental history of diabetes in non-diabetic Mexican-American subjects. Diabetes 44:1156-1160, 1995
8. Mykkanen L, Haffner SM, Hales CN, Ronnemaa T, Laakso M: The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990-1995, 1997
9. Roder ME, Dinesen B, Hartling SG, Houssa P, Vestergaard H, Sodoyez-Goffaux F, Binder C: Intact proinsulin and β-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 22:609-614, 1999
10. Vauhkonen IK, Niskanen LK, Mykkanen L, Haffner SM, Uusitupa MI, Laakso M: Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. Eur J Endocrinol 143:251-260, 2000
11. Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Zinman B: Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentration. J Clin Endocrinol Metab 87:77-83, 2002
12. Buchanan TA: Pancreatic β-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989-993, 2001
13. Dornhorst A, Davies M, Anyaoku V, Hampton SM, Elkeles RS, Beard RW, Johnston DG: Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol 34:211-213, 1991
14. Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhausl W, Pacini G, Prager R: Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46:607- 614, 1997
15. Festa A, Shnawa N, Schernthaner G, Haffner SM: Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 107:447-452, 1999
16. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B: C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 88:3507-3512, 2003
17. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B: Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 48:993-1001, 2005
18. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B: Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration. Diabet Med 21:388-392, 2004
19. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
20. Polonsky KS, Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin. Diabetes 33:486-494, 1984
21. Stumvoll M, Van Haeften TV, Fritsche A, Gerich J: Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24:796 -797, 2001
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes 28:412- 419, 1985
23. Matsuda M, DeFronzo R: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470, 1999
24. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM: Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 24:1602-1607, 2001
25. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A: Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab 64:661-668, 1987
26. Picard F, Wanatabe M, Schoonjans K, Lydon J, O'Malley BW, Auwerx J: Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta-cell proliferation. Proc Natl Acad Sci 99:15644-15648, 2002
27. Branisteanu DD, Mathieu C: Progesterone in gestational diabetes mellitus: guilty or not guilty? Trends Endocrinol Metab 14:54-56, 2003
28. Pradhan AD, Manson JE, Meigs JB, Rifai N, Buring JE, Liu S, Ridker PM: Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med 114:438-444, 2003
29. Persson B, Hanson U, Hartling SG, Binder C: Follow-up of women with previous GDM: insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes 40 (Suppl. 2):136 -141, 1991